Jean-François Rosier
Université catholique de Louvain
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Jean-François Rosier.
Radiotherapy and Oncology | 1998
Jean-François Rosier; Vincent Grégoire; Hubert Counoy; Michelle Octave-Prignot; Philippe Rombaut; Pierre Scalliet; Fabienne Vanderlinden; Marc Hamoir
PURPOSE The aim of this study was to retrospectively compare the efficacy and functional results of three treatment options for T1N0M0 glottic carcinomas applied in a single institution. MATERIALS AND METHODS One hundred six charts of patients with biopsy-proven T1N0M0 glottic carcinomas treated between 1979 and 1995 were reviewed. There were 81 T1a and 25 T1b tumors. Forty-one patients were treated by radiotherapy (RT) (median dose of 64 Gy), 34 patients were treated by partial laryngectomy (PL) and 31 patients were treated by laser microsurgery (L) of which 10 received postoperative RT for positive margins. In 18 patients, a perceptual voice rating on a visual scale was performed by the patients themselves, three non-speech specialists and two speech therapists. RESULTS With a median follow-up time of 63.5 months, the 5- and 10-year loco-regional control probabilities reached 91 and 87%, respectively, without any difference between the treatment groups. After salvage laryngectomy, the 5- and 10-year loco-regional control probabilities reached 97% without any difference between the treatment groups. For the whole population, overall survival reached 78 and 62.4% at 5 and 10 years, respectively. The actuarial incidence of second primary reached 19% at 10 years. Regarding the quality of voice, overall there was a trend towards a worse satisfaction index, more hoarseness and more breathiness after PL than after L or RT. CONCLUSIONS Our data suggested that assuming proper selection of patients, RT and L yielded similar outcomes and functional results. Local recurrence can be adequately salvaged by surgery. On the other hand, PL appeared to yield similar loco-regional control probability but with a worse quality of voice.
Radiotherapy and Oncology | 1999
Vincent Grégoire; Marc Hamoir; Jean-François Rosier; Hubert Counoy; Louis Eeckhoudt; Niels Neymark; Pierre Scalliet
Radiotherapy and Oncology | 2001
John Gueulette; Jacobus P. Slabbert; Lothar Böhm; Blanche M. De Coster; Jean-François Rosier; Michelle Octave-Prignot; Arnout C.C. Ruifrok; A Nicolaas Schreuder; André Wambersie; Pierre Scalliet; D. T. L. Jones
Radiotherapy and Oncology | 2002
Vincent Grégoire; Jean-François Rosier; Marc De Bast; M Bruniaux; Blanche M. De Coster; Michelle Octave-Prignot; Pierre Scalliet
Mutation Research | 2003
Jean-François Rosier; Lucienne Michaux; Geneviève Ameye; Björn Cedervall; Jeanne-Marie Libouton; M. Octaveprignot; Christine Verellen-Dumoulin; Pierre Scalliet; Vincent Grégoire
Radiotherapy and Oncology | 2004
Jean-François Rosier; M Bruniaux; Bernard Husson; Michelle Octave-Prignot; M. Beauduin; Vincent Grégoire
European Journal of Cancer | 1997
Jean-François Rosier; M. Beauduin; M Bruniaux; B M De Coster; M. De Bast; Pierre Scalliet; Vincent Grégoire
European Journal of Cancer | 1997
Vincent Grégoire; Marc Hamoir; J. Bussels; L. Eeckoudt; Hubert Counoy; Jean-François Rosier; Pierre Scalliet
Radiotherapy and Oncology | 1996
Jean-François Rosier; Hubert Counoy; Marc Hamoir; P. Lachmbre; Pierre Scalliet; Vincent Grégoire
Radiotherapy and Oncology | 1996
Vincent Grégoire; B M De Coster; Jean-François Rosier; M. Beauduin; M Bruniaux; M. Octaveprignot; Pierre Scalliet